Education Intervention to Increase Naltrexone Use Among Adult Inpatients With Alcohol Use Disorder

被引:1
|
作者
Ipsarides, Jason [1 ,2 ]
机构
[1] Med Coll Wisconsin, Dept Psychiat & Behav Med, Milwaukee, WI USA
[2] Med Coll Wisconsin, Dept Psychiat & Behav ioral Med, 8920 W Connell Court,Suite B510, Milwaukee, WI 53132 USA
关键词
PHARMACOTHERAPY; DEPENDENCE;
D O I
10.3928/02793695-20230424-03
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Alcohol use disorder (AUD) accounts for high rates of global deaths, disability, and health care spending. Naltrexone is an opioid antagonist used to reduce alcohol cravings. Despite demonstrated safety and efficacy, naltrexone is highly under-utilized in a variety of health care settings. The current quality improvement (QI) project aimed to increase knowledge and prescribing behaviors of naltrexone. A chart review of a purposive convenience sample was performed to determine the impact of the intervention. Staff participants completed a pre/posttest and a post-module survey. The primary objectives of the QI project were to increase the number of patients with AUD discharged with a prescription for naltrexone by 5% and achieve 50% staff participation in the online module, pre/posttest, and post -module survey. [Journal of Psychosocial Nursing and Mental Health Services, xx(x), xx-xx.]
引用
收藏
页码:10 / 14
页数:5
相关论文
共 50 条
  • [41] PREVALENCE AND CHARACTERISTICS OF ADULT ATTENTION-DEFICIT HYPERACTIVITY DISORDER AMONG SUBSTANCE USE INPATIENTS
    Abdelkarim, A.
    Salama, H.
    Latif, S. Abdel
    Abou El Magd, O.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [42] Smoking characteristics and alcohol use among women in treatment for alcohol use disorder
    Bold, Krysten W.
    Rosen, Rachel L.
    Steinberg, Marc L.
    Epstein, Elizabeth E.
    McCrady, Barbara S.
    Williams, Jill M.
    ADDICTIVE BEHAVIORS, 2020, 101
  • [43] NONMEDICAL SEDATIVE USE AMONG ADULTS WITH ALCOHOL USE DISORDER
    Votaw, V. R.
    Witkiewitz, K.
    McHugh, R. K.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 72A - 72A
  • [44] Association between hazardous alcohol use and initiation of naltrexone treatment for opioid use disorder among hiv-positive persons in russia
    Vetrova, M.
    Blokhina, E. A.
    Cheng, D. M.
    Truong, V.
    Quinn, E. K.
    Gnatienko, N.
    Bushara, N. M.
    Palatkin, V. Y.
    Vasilyeva, J. V.
    Yaroslavtseva, T. S.
    Krupitsky, E. M.
    Lioznov, D. A.
    Samet, J. H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S228 - S229
  • [45] EXTENDED-RELEASE NALTREXONE VERSUS ORAL NALTREXONE FOR ALCOHOL USE DISORDER TREATMENT IN PRIMARY CARE
    Chen, J.
    Obi, R.
    Wong, S.
    Flannery, M.
    McDonald, R.
    Tofighi, B.
    Kermack, A.
    Laska, E.
    Rotrosen, J.
    Gourevitch, M. N.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 40 : 233A - 233A
  • [46] Use of naltrexone in treating opioid use disorder in pregnancy
    Towers, Craig V.
    Katz, Emily
    Weitz, Beth
    Visconti, Kevin
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : 83.e1 - 83.e8
  • [47] Cognitive impairment in dual diagnosis inpatients with schizophrenia and alcohol use disorder
    Manning, Victoria
    Betteridge, Shai
    Wanigaratne, Shamil
    Best, David
    Strang, John
    Gossop, Michael
    SCHIZOPHRENIA RESEARCH, 2009, 114 (1-3) : 98 - 104
  • [48] Ketamine Infusion Experiences Among Medical Inpatients with Alcohol Use Disorder: Initial Findings of a Pilot RCT
    Terasaki, Dale
    Loh, Ryan
    Gaffaney, Michelle
    Thurstone, Christian
    JOURNAL OF THE ACADEMY OF CONSULTATION-LIAISON PSYCHIATRY, 2022, 63 : S101 - S102
  • [49] Feasibility, Acceptability, and Preliminary Outcomes of an Integrated Telemedicine Intervention Combining Naltrexone and Cognitive Behavioral Therapy for Alcohol Use Disorder
    Glasner, Suzette
    Webb, Jamie
    Michero, Darcy
    Motschman, Courtney
    Monico, Laura
    Ang, Alfonso
    Pielsticker, Peyton
    TELEMEDICINE REPORTS, 2022, 3 (01): : 184 - 190
  • [50] NALTREXONE FOR TREATING ADOLESCENT ALCOHOL USE
    Meisel, S. N.
    Carpenter, R. W.
    Miranda, R., Jr.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 46 : 44A - 44A